Lowering homocysteine doesn't reduce the risk of thromboembolismBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7606.1244-b (Published 14 June 2007) Cite this as: BMJ 2007;334:1244
Observational studies have found an association between raised total homocysteine concentrations in the serum and venous thromboembolism. Homocysteine is thought to promote thrombosis by enhancing platelet aggregation, increasing thrombin generation, impairing fibrinolysis, and causing endothelial dysfunction.
A placebo controlled trial carried out in 145 centres in 13 countries enrolled more than 5500 people who were over …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial